Explore the revolutionary advancements in next-generation antibody-drug conjugates (ADCs) for cancer therapy, including bispecific ADCs, novel payloads, and AI-driven development.
Explore how antibody-drug conjugates combine precision targeting with potent cancer-killing power to create revolutionary cancer treatments.